Jaipur Robotics Raises $5.0M Seed Funding

NovaGo Therapeutics

NovaGo’s fully human monoclonal antibodies have the potential to become a safe and effective treatment in central nervous system indications. NovaGo’s proprietary antibodies block the function of Nogo-A, one of the most potent and well-studied vascular and nerve growth inhibitors.

xorlab

xorlab is a European email security platform that blocks the advanced phishing attacks Microsoft 365 and on-premises filters miss. We help organisations move from reactive defence to proactive threat prevention with a behavioural AI email security solution built for complex, high-security, and highly regulated environments. The platform continuously learns and improves across its entire customer base while preserving the privacy of each individual organisation. Beyond enhanced threat prevention, it provides all the capabilities modern SOC teams require: from unparalleled visibility into email flows to powerful automation use cases, such as abuse mailbox handling, where employees can report suspicious emails and responses are intelligently automated using AI. Trusted by organisations ranging from 500 to 37,000+ employees, xorlab counts Julius Bär, Vontobel, University Hospital Zurich, and CERN among its customers. Organisations can deploy xorlab on premises with fully local processing and storage, in hybrid configurations, or in the cloud, where European data centres and EU-based staff handle all operations. The platform is built for critical infrastructure and other highly regulated environments and compliant with DORA, NIS2, and GDPR.